2023
Franklin M, Emden MR, Kautz S, Nguyen AT, Sacks NC , Ju S, Mitrani-Gold FS, Joshi AV, Preib MT. Cost burden of patients with oral antibiotic treatment failure for uncomplicated urinary tract infection in the United States. Poster presentation, IDWeek, October 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, Kaplan S, McMahon AW, Movva N , Raman SR, Scholle O, Suh M , Sun JW, Horton DB. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Poster presentation at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Nova Scotia, August 2023 [ISPE Journal ].
View Abstract
Topics: Epidemiology
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr PL , Sawyer EK, Stephen CD, Eichler F. Point of care analysis for men with adrenomyeloneuropathy: A retrospective study of real world data. Poster presentation, European Academy of Neurology, Budapest, Hungary, July 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen CD, Eichler F. Healthcare utilization, burden of illness, and mortality in adults with adrenomyeloneuropathy: The case for genetic therapies. Poster presentation, American Society of Cell and Gene Therapy Meeting, Los Angeles, CA, May 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Seo S, Healey B, McLin R, Sacks N , Benson C, Citrome L. Health disparities among patients with schizophrenia in an integrated healthcare system. Poster presentation, Psych Congress Elevate 2023, May 30-June 2, 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Jensen I , Srivastava K, Minshall M, Kemp R. Estimating the lifetime burden of illness in patients with bronchiolitis obliterans syndrome. Abstract EE539 . ISPOR 2023.
View Abstract
Topics: bronchiolitis obliterans , cost-consequence , cost-utility analysis , Health Economics and Outcomes Research (HEOR)
Bean K, Miller B, Jensen I , Fields C, Pang F. Evaluating the face validity of health state utility values (HSUVS) for metachromatic leukodystrophy (MLD). Abstract EE285 . ISPOR 2023.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Bean K, Olaye A, Miller B, Jensen I , Dean R, Pang F. Direct cost analysis associated with the management of patients with metachromatic leukodystrophy (MLD) across nine European countries. Abstract EE408 . ISPOR 2023.
View Abstract
Topics: Metachromatic leukodystrophy (MLD)
Minshall M, Emden M, McLin R, Kemp P, Pontenani F, Cardosi L, Sacks N . The cost of non-cystic fibrosis bronchiectasis (NCFB) in patients with commercial insurance or Medicare coverage in the US. Poster presentation, ISPOR, April 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen CD, Eichler F. Substantial burden of illness and mortality in men with adrenomyeloneuropathy. Poster presentation at American Academy of Neurology Annual Meeting, April 2023.
A Division of